studi
object
absenc
reliabl
rapid
confirmatori
test
sever
acut
respiratori
syndrom
sar
endem
design
cohort
studi
establish
score
system
sar
evalu
whether
could
improv
sensit
specif
world
health
organ
criteria
method
accord
clinic
characterist
initi
laboratori
find
suspect
case
defin
criteria
confirm
case
sar
univers
teach
hospit
taipei
march
april
score
system
sar
design
multivari
analysi
stepwis
logist
regress
simpl
arithmet
sum
point
valu
assign
paramet
thereaft
appli
score
system
sar
consecut
patient
valid
group
met
criteria
suspect
case
april
may
final
diagnosi
sar
determin
result
realtim
polymeras
chain
reaction
pair
serum
result
score
system
sar
defin
radiograph
find
multilobar
bilater
infiltr
point
sputum
monocyt
predomin
point
lymphocytopenia
point
histori
exposur
point
lactat
dehydrogenas
ul
point
creactiv
protein
mgdl
point
activ
partial
prothrombin
time
second
point
valid
group
patient
group
confirm
case
sar
group
b
patient
test
neg
sar
total
point
score
system
sar
initi
present
significantli
higher
sar
group
median
rang
nonsar
group
median
rang
p
cutoff
valu
point
sensit
specif
score
system
sar
diagnos
sar
respect
posit
neg
predict
valu
score
system
sar
respect
conclus
score
system
sar
provid
rapid
reliabl
clinic
decis
help
emerg
physician
detect
case
sar
accur
endem
area
possibl
low
sensit
criteria
report
studi
includ
develop
score
system
sar
cohort
popul
valid
second
cohort
febril
patient
consult
institut
univers
teach
hospit
account
popul
taipei
taiwan
met
criteria
suspect
sar
prospect
enrol
studi
begin
march
histori
exposur
associ
symptom
cough
dyspnea
myalgia
diarrhea
rigor
record
patient
complet
evalu
isol
facil
emerg
depart
ed
within
hour
underw
cbc
count
differenti
count
clot
profil
prothrombin
time
activ
partialthromboplastin
time
intern
normal
ratio
biochem
measur
addit
chest
radiograph
obtain
throat
swab
sputum
collect
gram
stain
screen
test
common
virus
notabl
influenza
b
respiratori
syncyti
viru
legionella
pneumococc
urinari
antigen
test
also
examin
final
diagnosi
sar
document
center
diseas
control
taiwan
polymeras
chain
reaction
pair
serum
coronaviru
antibodi
measur
posit
polymeras
chain
reaction
posit
pair
serum
patient
confirm
sar
patient
consid
probabl
case
accord
criteria
admit
other
dispos
isol
home
day
convalesc
serum
obtain
admiss
former
patient
day
clinic
latter
patient
anyon
clinic
deterior
home
isol
immedi
transport
back
hospit
ambul
protocol
approv
institut
review
board
inform
consent
obtain
perform
multivari
analysi
deriv
risk
score
base
deriv
patient
complet
data
present
univari
relationship
baselin
characterist
includ
clinic
symptom
sign
radiolog
laboratori
examin
mention
previous
diagnosi
sar
assess
logist
regress
analysi
independ
predictor
sar
identi
sever
acut
respiratori
syndrom
sar
diseas
manifest
atyp
pneumonia
rapid
progress
respiratori
distress
proven
caus
coronaviru
accord
definit
world
health
organ
characterist
suspect
case
document
fever
bodi
temperatur
lower
respiratori
symptom
contact
index
patient
patient
chest
radiograph
find
pneumonia
acut
respiratori
distress
syndrom
unexplain
respiratori
diseas
result
death
autopsi
result
demonstr
patholog
compar
sar
consid
probabl
case
although
provid
guidelin
sar
control
diagnost
tool
polymeras
chain
reaction
indirect
fluoresc
antibodi
enzymelink
immunosorb
assay
antibodi
develop
still
mani
clinic
difficulti
diagnos
diseas
quickli
exampl
sensit
polymeras
chain
reaction
still
uncertain
antibodi
titer
may
detect
day
onset
sar
difficult
issu
emerg
physician
detect
patient
sar
specif
neither
reliabl
histori
exposur
rapid
diagnost
tool
recent
epidemiolog
studi
hong
kong
canada
demonstr
clinic
characterist
import
laboratori
find
sar
improv
test
predict
model
exist
establish
diagnosi
sever
acut
respiratori
syndrom
sar
emerg
depart
ed
set
sar
diagnost
score
system
use
inform
avail
ed
develop
suspect
sar
case
valid
subsequ
case
score
system
base
radiograph
infiltr
histori
exposur
laboratori
test
help
discrimin
true
sar
case
although
score
system
may
perform
well
area
differ
sar
epidemiolog
import
first
step
develop
diagnost
strategi
new
ill
signific
predictor
sar
tabl
addit
regress
model
demonstr
good
discriminatori
capac
c
statist
characterist
account
predict
capac
multivari
model
select
inclus
score
system
sar
accordingli
score
system
sar
defin
radiograph
find
multilobar
bilater
infiltr
point
monocyt
predomin
sputum
gram
stain
defin
monocyt
polymorph
point
peripher
lymphocyt
less
l
point
histori
exposur
index
patient
point
lactat
dehydrogenas
ul
upper
normal
limit
ul
point
creactiv
protein
mgdl
upper
normal
limit
mgdl
immag
immunochemistri
system
beckman
coulter
fullerton
ca
point
activ
partial
prothrombin
time
second
point
prospect
test
diagnost
accuraci
score
system
sar
sinc
april
total
patient
suspect
sar
enrol
test
predict
capac
score
system
fie
stepwis
logist
regress
variabl
present
enter
initi
model
maintain
p
valu
less
select
independ
predictor
inclus
score
system
sar
base
rel
predict
contribut
full
logist
regress
model
variabl
rank
z
score
least
contribut
sequenti
remov
model
variabl
captur
overal
prognost
inform
full
multivari
model
evalu
ratio
global
statist
reduc
compar
full
model
reach
patient
score
system
sar
calcul
simpl
arithmet
sum
point
valu
assign
risk
factor
accord
multivariateadjust
risk
relationship
point
odd
ratio
less
point
point
evalu
risk
score
suspect
case
miss
variabl
contribut
point
valu
total
score
discriminatori
capac
risk
score
assess
use
area
receiv
oper
characterist
roc
curv
index
model
perform
deriv
valid
phase
roc
curv
reflect
concord
predict
actual
outcom
rank
order
roc
curv
deriv
phase
studi
patient
enrol
march
april
develop
score
system
sar
patient
consult
ed
met
criteria
suspect
sar
twenti
patient
confirm
case
sar
wherea
patient
test
neg
sar
initi
clinic
characterist
evalu
univari
analysi
tabl
candid
variabl
assess
simultan
multivari
analysi
remain
tabl
tim
group
score
system
sar
least
point
twelv
patient
group
b
point
remain
score
system
sar
less
equal
point
cutoff
valu
point
sensit
specif
score
system
sar
respect
posit
neg
predict
valu
respect
contrast
sensit
criteria
suspect
case
sensit
specif
criteria
probabl
case
respect
posit
neg
predict
valu
respect
still
limit
studi
first
coronaviru
pathogen
sar
report
mani
genet
variat
whether
genet
variat
produc
differ
clinic
manifest
remain
elucid
therefor
score
system
sar
may
continu
modifi
maintain
diagnost
reliabl
second
patient
coronaviru
bacteri
infect
acinetobact
sp
pneumonia
mix
infect
may
produc
confus
clinic
pictur
reduc
accuraci
score
system
sar
diagnos
sar
third
score
system
sar
clinic
decis
rule
suspect
case
sar
instead
sar
group
common
present
earli
stage
presenc
abnorm
chest
radiograph
result
follow
monocytepredomin
sputum
smear
patient
sar
sputum
smear
patient
whose
sputum
sampl
could
obtain
lymphocytopenia
elev
lactat
dehydrogenas
level
abnorm
creactiv
protein
level
tabl
criteria
prolong
partial
prothrombin
time
thrombocytopenia
abnorm
creatin
kinas
level
alanin
transaminas
depict
tabl
met
patient
contrast
patient
nonsar
group
significantli
lower
incid
manifest
tabl
total
point
score
system
sar
initi
present
significantli
higher
sar
group
median
rang
nonsar
group
median
rang
p
vic
seem
rel
high
still
high
enough
miss
rate
could
becom
pitfal
surveil
possibl
caus
devast
event
endem
area
perfect
clinic
decis
rule
infecti
diseas
sensit
score
system
sar
provid
use
algorithm
might
also
partial
account
absenc
hospit
staff
infect
institut
event
data
demonstr
monocyt
predomin
sputum
smear
present
critic
find
earli
stage
sar
although
patient
might
dri
cough
scanti
sputum
result
rel
low
avail
data
seri
still
strongli
recommend
examin
sputum
smear
strong
posit
predict
valu
sar
low
cost
prompt
earli
diagnosi
studi
focus
earli
manifest
sar
instead
fullblown
characterist
seri
patient
sar
similar
clinic
manifest
hospit
investig
hong
kong
report
patient
sar
studi
temperatur
higher
cough
myalgia
along
whole
cours
overal
laboratori
find
hospit
includ
lymphocytopenia
thrombocytopenia
elev
lactat
dehydrogenas
ul
increas
creactiv
protein
mgdl
prolong
activ
partial
thromboplastin
time
second
fullblown
manifest
differ
initi
present
emerg
physician
alway
observ
summari
absenc
avail
diagnost
tool
provid
confirmatori
result
earli
stage
score
system
sar
help
emerg
physician
make
rapid
accur
diagnosi
sar
quickli
costeffici
author
contribut
author
jointli
collect
clinic
data
patient
tlw
ch
design
studi
revis
manuscript
tnj
chh
sjk
assist
construct
analyt
data
file
dh
cml
respons
statist
analysi
tlw
take
respons
paper
whole
screen
tool
gener
popul
sensit
specif
score
may
expect
differ
patient
popul
differ
mixtur
comorbid
set
outbreak
respiratori
diseas
influenza
major
global
outbreak
sar
although
confirmatori
test
polymeras
chain
reaction
measur
coronaviru
antibodi
conduct
mani
laboratori
still
provid
instant
correct
inform
clinician
initi
criteria
may
help
screen
suspect
probabl
case
low
specif
may
indic
lack
costeffect
endem
area
studi
demonstr
score
system
sar
simpl
reliabl
clinic
decis
rule
help
emerg
clinician
detect
patient
sar
quickli
costeffici
endem
time
usual
chao
isol
facil
suffici
criteria
could
discrimin
definit
victim
sar
nonsar
febril
patient
report
reveal
criteria
probabl
case
specif
patient
met
criteria
suspect
case
mean
ought
least
reserv
isol
facil
medic
cost
probabl
case
admit
hospit
averag
expenditur
case
complet
workup
score
system
sar
approxim
us
seri
wherea
medic
cost
admiss
us
per
day
although
total
expenditur
complet
score
system
sar
valid
patient
approxim
us
method
save
least
unnecessari
admiss
us
averag
durat
admiss
day
addit
rapid
screen
test
common
virus
legionella
pneumococc
urinari
antigen
test
protocol
mainli
confirm
final
diagnosi
establish
valid
score
system
sar
primari
object
develop
score
system
use
common
laboratori
radiograph
examin
avail
ed
instead
rapid
test
word
rapid
screen
test
avail
score
system
still
work
well
sensit
criteria
suspect
case
wherea
criteria
probabl
case
sensit
latter
